Related Experiment Video
Updated: Jan 28, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors
Eric Krawczyk1, Sergey N Zolov1, Kevin Huang1
1Department of Pediatrics and Communicable Diseases, Division of Pediatric Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
Engineered T cells targeting acute myeloid leukemia (AML) show promise. Dual-targeting T cells (CLEC12A-ENG.CD123IL7Rα) enhance AML killing and antitumor activity, improving treatment potential.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Engineered T cells offer potential for treating acute myeloid leukemia (AML).
- Challenges include identifying suitable targets and ensuring T cell persistence.
- Current therapies require novel strategies for enhanced efficacy.
Purpose of the Study:
- To develop novel T cells for improved AML treatment.
- To enhance T cell activation and antitumor activity through dual-targeting.
- To investigate the role of chimeric IL7 receptor in T cell function.
Main Methods:
- Designed CLEC12A-specific T cells secreting a bispecific engager (CLEC12A-ENG).
- Developed dual-targeting T cells (CLEC12A-ENG.CD123IL7Rα) with a chimeric IL7 receptor targeting CD123.
- Assessed T cell activation, AML killing, and in vivo antitumor activity in xenograft models.
Main Results:
- CLEC12A-ENG T cells specifically killed AML cells without harming hematopoietic progenitors.
- Dual-targeting T cells demonstrated enhanced activation upon recognizing both CLEC12A and CD123.
- CLEC12A-ENG.CD123IL7Rα T cells exhibited significant antitumor activity in vivo.
- Enhanced T cell activation was dependent on CD123 recognition and IL7Rα signaling.
Conclusions:
- Dual-targeting engineered T cells show improved efficacy against AML.
- Chimeric IL7 receptor strategies enhance T cell activity by dual target recognition.
- This approach holds potential for treating hematologic malignancies and other cancers.
More Related Videos
Related Concept Videos
Types of Receptors: Cell Surface Receptors
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
What is Cell Signaling?
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-surface Signaling
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
